NCT04114890View on ClinicalTrials.gov

Tenofovir in Pregnancy to Prevent Mother to Child Transmission of Hepatitis B.

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

January 8, 2021

Primary Completion Date

September 29, 2023

Study Completion Date

September 29, 2023

Conditions
Hepatitis BTenofovirPregnancy
Interventions
DRUG

Tenofovir Disoproxil Fumarate

Tenofovir Disoproxil Fumarate 300 mg once daily and will continue until one month after delivery

Trial Locations (1)

63110

Shoklo Malaria Research unit (SMRU) clinics, Mae Sot

All Listed Sponsors
lead

University of Oxford

OTHER

NCT04114890 - Tenofovir in Pregnancy to Prevent Mother to Child Transmission of Hepatitis B. | Biotech Hunter | Biotech Hunter